382 filings
Page 14 of 20
6-K
BNTX
BioNTech SE
9 Nov 20
Current report (foreign)
5:13pm
6-K
BNTX
BioNTech SE
9 Nov 20
Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study
8:28am
6-K
BNTX
BioNTech SE
16 Oct 20
Current report (foreign)
7:54am
6-K
BNTX
BioNTech SE
6 Oct 20
Current report (foreign)
7:19am
D
BNTX
BioNTech SE
17 Sep 20
$250M in equity / debt, sold $250M, 2 investors
8:26am
6-K
BNTX
BioNTech SE
17 Sep 20
BioNTech to Acquire GMP Manufacturing Site to Expand COVID-19 Vaccine Production Capacity in First Half 2021
7:00am
6-K
BNTX
BioNTech SE
15 Sep 20
BioNTech to Receive up to €375M in Funding from German Federal Ministry of Education and Research to Support COVID-19 Vaccine Program BNT162
6:54am
6-K
BNTX
BioNTech SE
14 Sep 20
Current report (foreign)
7:16am
6-K
BNTX
BioNTech SE
9 Sep 20
Pfizer and BioNTech Announce Data From
8:08am
6-K
BNTX
BioNTech SE
9 Sep 20
Current report (foreign)
6:26am
424B3
BNTX
BioNTech SE
27 Aug 20
Prospectus supplement
5:18pm
424B3
BNTX
BioNTech SE
21 Aug 20
Prospectus supplement
5:26pm
6-K
BNTX
BioNTech SE
20 Aug 20
Current report (foreign)
8:31pm
6-K
BNTX
BioNTech SE
18 Aug 20
Current report (foreign)
5:05pm
424B3
BNTX
BioNTech SE
12 Aug 20
Prospectus supplement
5:14pm
6-K
BNTX
BioNTech SE
12 Aug 20
Current report (foreign)
6:22am
424B3
BNTX
BioNTech SE
11 Aug 20
Prospectus supplement
5:13pm
6-K
BNTX
BioNTech SE
11 Aug 20
BioNTech Announces Second Quarter 2020 Financial Results and Corporate Progress
7:07am
424B3
BNTX
BioNTech SE
5 Aug 20
Prospectus supplement
4:33pm
6-K
BNTX
BioNTech SE
5 Aug 20
Supply to be provided over the course of 2021, subject to Health Canada approval
8:33am